Sol-Gel Technologies Ltd. Ordinary Shares (SLGL)
Stock · NASDAQ · Health Care
$64.43as of 10/16/2026
Price chart
Active signals
SLGL Signal Track Record
How signals performed across all stocks →What SLGL's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 24 | +0.3% | 50% | August 28, 2026 |
| Bollinger Band Breakout | 18 | +1.6% | 50% | October 5, 2026 |
| Volume Spike | 19 | +8.5% | 74% | September 1, 2026 |
| Any 20-session window (baseline) | -3.1% | 43% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SLGL
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustula…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 28
- Website
- www.sol-gel.com
Fundamentals
- 1-day range
- $62.66$69.1
- Market cap
- $244.18M
- P/E (trailing)
- —
- P/E (forward)
- -8.00
- EPS (trailing)
- $-5.64
- Dividend yield
- —
- Beta
- 1.25
- Avg. volume
- 54.5K
Forecasts
2 analyst ratings
Sol-Gel Technologies Ltd. Ordinary Shares Competitors
Chosen by industry and closest market cap.
- SLGLSol-Gel Technologies Ltd. Ordinary Shares$64.25▼ 6.48%Market cap $244.18MP/E —$28.81$97.97
- CAPRCapricor Therapeutics Inc. Common Stock$6.71▼ 7.70%Market cap $242.07MP/E —$2.96$40.37
- PYXSPyxis Oncology Inc. Common Stock$1.68▼ 6.67%Market cap $237.58MP/E —$1.03$5.55
- ACIUAC Immune SA Common Stock$2.39▼ 2.45%Market cap $236.11MP/E —$2.1$4
- WHWKWhitehawk Therapeutics Inc. Common Stock$2.89▼ 4.93%Market cap $252.78MP/E —$1.97$5.5
- MGNXMacroGenics Inc. Common Stock$3.25▼ 3.56%Market cap $254.89MP/E —$1.29$5.08
- AKBAAkebia Therapeutics Inc. Common Stock$0.67▼ 3.74%Market cap $256.03MP/E —$0.7$3.2
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SLGL Sol-Gel Technologies Ltd. Ordinary Shares | $244.18M | — | $64.25 | ▼ 6.48% | $28.81$97.97 |
| CAPR Capricor Therapeutics Inc. Common Stock | $242.07M | — | $6.71 | ▼ 7.70% | $2.96$40.37 |
| PYXS Pyxis Oncology Inc. Common Stock | $237.58M | — | $1.68 | ▼ 6.67% | $1.03$5.55 |
| ACIU AC Immune SA Common Stock | $236.11M | — | $2.39 | ▼ 2.45% | $2.1$4 |
| WHWK Whitehawk Therapeutics Inc. Common Stock | $252.78M | — | $2.89 | ▼ 4.93% | $1.97$5.5 |
| MGNX MacroGenics Inc. Common Stock | $254.89M | — | $3.25 | ▼ 3.56% | $1.29$5.08 |
| AKBA Akebia Therapeutics Inc. Common Stock | $256.03M | — | $0.67 | ▼ 3.74% | $0.7$3.2 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- This Entegris Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesdaybenzinga · 10/14/2026
- SolGel Technologies (SLGL) Upgraded to Buy: Here's WhyYahoo · 10/8/2026
- Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026Yahoo · 9/30/2026
- SolGel Technologies (SLGL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?Yahoo · 9/17/2026
- Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin SyndromeYahoo · 9/17/2026
Insider Activity
Insider Actions →- Opaleye Management Inc. · September 11, 2026 · Buy1.5K @ $65.95
- Opaleye Management Inc. · September 10, 2026 · Buy1.6K @ $66.8
- Opaleye Management Inc. · September 9, 2026 · Buy3.1K @ $68.71
- Opaleye Management Inc. · September 8, 2026 · Buy471 @ $69.37
- Opaleye Management Inc. · September 8, 2026 · Buy3.4K @ $68.74
- Opaleye Management Inc. · September 4, 2026 · Buy918 @ $69.52
- Opaleye Management Inc. · September 4, 2026 · Buy2.1K @ $68.98
- Opaleye Management Inc. · September 2, 2026 · Buy900 @ $68.95
- Opaleye Management Inc. · September 1, 2026 · Buy783 @ $69.52
- Opaleye Management Inc. · August 31, 2026 · Buy217 @ $69.1
- Opaleye Management Inc. · August 31, 2026 · Buy5.0K @ $68.24
- Opaleye Management Inc. · August 28, 2026 · Buy5.0K @ $68.81
- Opaleye Management Inc. · August 28, 2026 · Buy20.1K @ $68.42
- Opaleye Management Inc. · August 28, 2026 · Buy10.0K @ $71.4
- Opaleye Management Inc. · August 12, 2026 · Buy951 @ $71.5
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Sol-Gel Technologies Announces Investor Day for SGT-610
Sol-Gel Technologies has announced it will host a KOL Investor Day for its SGT-610 product on October 14, 2026. The event will bring together key opinion leaders to discuss the product's progress and future plans. Investors can expect additional details on SGT-610’s development and potential market impact.
Sol-Gel Technologies Announces Investor Day for SGT-610. Sol-Gel Technologies has announced it will host a KOL Investor Day for its SGT-610 product on October 14, 2026. The event will bring together key opinion leaders to discuss the product's progress and future plans. Investors can expect additional details on SGT-610’s development and potential market impact.